India Cancer Treatment Drugs Market Insights, Share & Growth Trends 2025 to 2030

Markntel Advisors’ report, India Cancer Treatment Drugs Research Report: Trend, Business Growth, Size, Future Scope, Segmentation, Dynamics, and Forecast to 2030, offers a comprehensive guide for the growing industry. The expert team of analysts dedicated significant effort to gathering and evaluating the latest market data, resulting in a detailed and up-to-date report that offers valuable insights for individuals who rely on data-driven decisions, including business owners and analysts. The research report on the India Cancer Treatment Drugs presents well-researched facts and figures pertinent to the industry, whether the goal is to explore new markets, launch a new product, or maintain a competitive advantage.

India Cancer Treatment Drugs Market Research Report & Market Summary:

The India Cancer Treatment Drugs Market is projected to grow at a CAGR of around 12.2% during the forecast period, i.e., 2025-30. With estimated 1.39 million cancer cases in 2020, the disease has become a public health concern in India. Earlier, the total number of deaths from cancer in India was more than 0.8 million in 2019. It is estimated that one woman dies of cervical cancer every 8 minutes in India due to cancer, according to the National Institute of Cancer Prevention and Research. Of every two women newly diagnosed with breast cancer, one dies of it in India. Moreover, tobacco consumption in the country is burgeoning, thereby mounting the total number of deaths from tobacco cancer.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/india-cancer-treatment-market.html

India Cancer Treatment Drugs Market Dynamics:

Key Driver-

Numerous Schemes Encouraging Affordable & Effective Cancer Diagnosis &Treatment - Cancer treatment has been one of the main focal areas of the Pradhan Mantri Jan Arogya Yojana in order to protect the beneficiaries from the catastrophic costs of cancer treatment. The delivery of services under the Ayushman Bharat Health and Wellness Centers (AB-HWCs) includes screening for three common malignancies, including oral, breast, and cervical cancers and other common non-communicable diseases.

Along similar lines, The National Pharmaceutical Pricing Authority (NPPA), which is part of the Ministry of Chemicals and Fertilizers, released a list of 390 non-scheduled anti-cancer medications in 2019 with MRP reductions of up to 87%. This action helped 22 lakh cancer patients in the nation and would save consumers about Rs. 800 crores annually. Following a decade of caution and organic growth, Indian pharmaceutical businesses are currently on an acquisition binge. And cancer medications seem to be their primary focus, thus driving the drug industry in the long run.

India Cancer Treatment Drugs Market Segmentation Analysis:

According to MarkNtel study the market is segmented into the following categories:

By Treatment Type

Chemotherapy- Market Size & Forecast 2020-2030, USD Million
Targeted Therapy- Market Size & Forecast 2020-2030, USD Million
Immunotherapy- Market Size & Forecast 2020-2030, USD Million
Hormonal Therapy- Market Size & Forecast 2020-2030, USD Million
Other Treatment Types- Market Size & Forecast 2020-2030, USD Million

The Targeted Therapy segment acquired the largest share of the India Cancer Treatment Drugs Market during the historical period.

By Drug Class

Cytotoxic Drugs- Market Size & Forecast 2020-2030, USD Million
- Alkylating Agents- Market Size & Forecast 2020-2030, USD Million
- Antimetabolites- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
Targeted Drugs- Market Size & Forecast 2020-2030, USD Million
- Monoclonal Antibodies- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
Hormonal Drugs- Market Size & Forecast 2020-2030, USD Million
Others- Market Size & Forecast 2020-2030, USD Million

The majority of highest-priority medicines were conventional cytotoxic therapy. Well-established cytotoxic drugs, exposed to global generic competition in the past 10-20 years, include doxorubicin, cyclophosphamide, paclitaxel, carboplatin, methotrexate, cytarabine, capecitabine, fluorouracil, and gemcitabine. Likewise, Generic Chemotherapy agents are the most high-priority cancer medicines by Indian oncologists as they facilitate substantial improvements in survival and are already included in WHO EML.

By Type

Blood Cancer- Market Size & Forecast 2020-2030, USD Million
Breast Cancer- Market Size & Forecast 2020-2030, USD Million
Colorectal Cancer- Market Size & Forecast 2020-2030, USD Million
Cervical Cancer- Market Size & Forecast 2020-2030, USD Million
Prostate Cancer- Market Size & Forecast 2020-2030, USD Million
Gastrointestinal Cancer- Market Size & Forecast 2020-2030, USD Million
Gynecologic Cancer- Market Size & Forecast 2020-2030, USD Million
Non-Hodgkin’s Cancer- Market Size & Forecast 2020-2030, USD Million
Respiratory/ Lung Cancer- Market Size & Forecast 2020-2030, USD Million
Stomach Cancer- Market Size & Forecast 2020-2030, USD Million
Other Cancers- Market Size & Forecast 2020-2030, USD Million

By Dosage Form

Solid- Market Size & Forecast 2020-2030, USD Million
- Tablets- Market Size & Forecast 2020-2030, USD Million
- Capsules- Market Size & Forecast 2020-2030, USD Million
Liquid- Market Size & Forecast 2020-2030, USD Million
Injectable- Market Size & Forecast 2020-2030, USD Million
- Prefilled Syringes- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million

By End-Users

Hospitals- Market Size & Forecast 2020-2030, USD Million
Specialty Clinics- Market Size & Forecast 2020-2030, USD Million
Cancer and Radiation Therapy Centers- Market Size & Forecast 2020-2030, USD Million

By Distribution Channel

Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
Online Pharmacies- Market Size & Forecast 2020-2030, USD Million

By Region

North
South
East
West.

As indicated in the latest market research report published by Markntel Advisors, “India Cancer Treatment Drugs Research Report: Forecast (2025-2030)”, this report offers a detailed analysis of the industry, featuring insights into the India Cancer Treatment Drugs industry. It encompasses competitor and geographical analyses, as well as recent advancements in the market.

Browse Full Report Along with TOC and Figures - https://www.marknteladvisors.com/research-library/india-cancer-treatment-market.html

Top Companies Operating in the India Cancer Treatment Drugs Market:

Amgen
Astellas Pharma Inc.
AstraZeneca
Bayer
Bristol-Myers Squibb Company
Cipla
Hoffmann- La- Roche
Merck KGaA
Natco Pharma
Novartis AG

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*

Other Report:

GCC Municipal Waste Management Market size is valued at around USD25Billion in 2024 and is estimated to grow at a CAGR of around 6.2% during 2024-2030.
Explore the booming GCC Herbal Medicine Market, projected to reach USD 366Million by 2030, with a CAGR of 6.90%. Discover key drivers, trends, and Market insights for Saudi Arabia, UAE, and more.

Key Report Highlights:

Market Dimensions & Projections
Pricing Evaluation,
Recent Strategic Moves by Companies,
Primary Stakeholders,
Analysis of Import and Export Trends,
Competitive Landscape Assessment,
Emerging Opportunities,
Market Trends and Indicators

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

Frequently Asked Questions (FAQs)-

What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
What are the trends influencing the current scenario of the market?
What leading factors would propel and impede the industry across the geography?
How has the industry been evolving in terms of geography & India Cancer Treatment Drugs Market adoption?
How has the competition been shaping up across the geography?

Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.